Forming of demethoxycurcumin nanocrystallite-chitosan nanocarrier for controlled low dose cellular release for inhibition of the migration of vascular smooth muscle cells

Molecular Pharmaceutics

Volumn 9, Issue 8, 2012, Pages 2268-2279

  Wang, Yen Jen ^a   Lin, Hui Yi ^b   Wu, Chieh Hsi ^b   Liu, Dean Mo ^a  

^a NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

amphiphilic chitosan; cellular drug release; cellular migration; demethoxycurcumin; vascular smooth muscle cell

Indexed keywords

AMPHOPHILE; CARBOMETHYL HEXANOL CHITOSAN; CHITOSAN; DEMETHOXYCURCUMIN; DRUG CARRIER; GELATINASE A; GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NANOCARRIER; NANOCRYSTAL; NANOPARTICLE; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CELL GROWTH; CELL MIGRATION; CELLULAR DISTRIBUTION; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CYTOTOXICITY; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG POTENCY; GROWTH INHIBITION; INTERNALIZATION; MIGRATION INHIBITION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; SURFACE PROPERTY; VASCULAR SMOOTH MUSCLE;

CELL LINE; CELL MOVEMENT; CELL SURVIVAL; CHITOSAN; CURCUMIN; DRUG CARRIERS; FLOW CYTOMETRY; HUMANS; MICROSCOPY, FLUORESCENCE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NANOPARTICLES;

EID: 84864714797     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp300150q     Document Type: Article

References (54)

1. Willis, A. I.; Pierre-Paul, D.; Sumpio, B. E.; Gahtan, V. Vascular smooth muscle cell migration: current research and clinical implications Vasc. Endovasc. Surg. 2004, 38 (1) 11-23 (Pubitemid 38140268)
2. Esteban, V.; Mendez-Barbero, N.; Jimenez-Borreguero, L. J.; Roque, M.; Novensa, L.; Garcia-Redondo, A. B.; Salaices, M.; Vila, L.; Arbones, M. L.; Campanero, M. R.; Redondo, J. M. Regulator of calcineurin 1 mediates pathological vascular wall remodeling J. Exp. Med. 2011, 208 (10) 2125-39
3. Autieri, M. V. Allograft-induced proliferation of vascular smooth muscle cells: potential targets for treating transplant vasculopathy Curr. Vasc. Pharmacol. 2003, 1 (1) 1-9
4. Hong, Y. J.; Jeong, M. H.; Song, S. J.; Sim, D. S.; Kim, J. H.; Lim, K. S.; Hachinohe, D.; Ahmed, K.; Hwang, S. H.; Lee, M. G.; Ko, J. S.; Park, K. H.; Yoon, H. J.; Yoon, N. S.; Kim, K. H.; Park, H. W.; Ahn, Y.; Cho, J. G.; Cho, D. L.; Park, J. C.; Kang, J. C. Effects of ramiprilat-coated stents on neointimal hyperplasia, inflammation, and arterial healing in a porcine coronary restenosis model Korean Circ. J. 2011, 41 (9) 535-41
5. Regan, C. P.; Adam, P. J.; Madsen, C. S.; Owens, G. K. Molecular mechanisms of decreased smooth muscle differentiation marker expression after vascular injury J. Clin. Invest. 2000, 106 (9) 1139-47
6. Pollman, M. J.; Hall, J. L.; Gibbons, G. H. Determinants of vascular smooth muscle cell apoptosis after balloon angioplasty injury. Influence of redox state and cell phenotype Circ. Res. 1999, 84 (1) 113-21 (Pubitemid 29074886)
7. Szocs, K.; Lassegue, B.; Sorescu, D.; Hilenski, L. L.; Valppu, L.; Couse, T. L.; Wilcox, J. N.; Quinn, M. T.; Lambeth, J. D.; Griendling, K. K. Upregulation of Nox-based NAD(P)H oxidases in restenosis after carotid injury Arterioscler. Thromb. Vasc. Biol. 2002, 22 (1) 21-7 (Pubitemid 34076227)
8. Lim, Y.; Tudev, M.; Park, E. S.; Kim, W. S.; Lim, I. H.; Lee, M. Y.; Lee, H.; Jung, J. K.; Hong, J. T.; Yoo, H. S.; Lee, M. K.; Pyo, M. Y.; Yun, Y. P. Inhibitory effects of OD 78 [3-(4-bromo-phenoxy)-4,5-dihydroxybenzoic acid-methyl ester] on the proliferation and migration of TNF-alpha-induced rat aortic smooth muscle cells Arch. Pharmacal Res. 2011, 34 (7) 1191-9
9. Lee, K. J.; Hinek, A.; Chaturvedi, R. R.; Almeida, C. L.; Honjo, O.; Koren, G.; Benson, L. N. Rapamycin-eluting stents in the arterial duct: experimental observations in the pig model Circulation 2009, 119 (15) 2078-85
10. Kim, H. J.; Cha, B. Y.; Choi, B.; Lim, J. S.; Woo, J. T.; Kim, J. S. Glyceollins inhibit platelet-derived growth factor-mediated human arterial smooth muscle cell proliferation and migration Br. J. Nutr. 2011, 1-12
11. Chen, H. W.; Huang, H. C. Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells Br. J. Pharmacol. 1998, 124 (6) 1029-40
12. Jang, H. S.; Nam, H. Y.; Kim, J. M.; Hahm, D. H.; Nam, S. H.; Kim, K. L.; Joo, J. R.; Suh, W.; Park, J. S.; Kim, D. K.; Gwon, H. C. Effects of curcumin for preventing restenosis in a hypercholesterolemic rabbit iliac artery stent model Catheterization Cardiovasc. Interventions 2009, 74 (6) 881-8
13. Lopez-Lazaro, M. Anticancer and carcinogenic properties of curcumin: considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent Mol. Nutr. Food Res. 2008, 52 (Suppl. 1) S103-27
14. Jayaprakasha, G. K.; Jagan Mohan Rao, L.; Sakariah, K. K. Improved HPLC method for the determination of curcumin, demethoxycurcumin, and bisdemethoxycurcumin J. Agric. Food Chem. 2002, 50 (13) 3668-72 (Pubitemid 34640688)
15. Kim, D. S.; Park, S. Y.; Kim, J. K. Curcuminoids from Curcuma longa L. (Zingiberaceae) that protect PC12 rat pheochromocytoma and normal human umbilical vein endothelial cells from betaA(1-42) insult Neurosci. Lett. 2001, 303 (1) 57-61 (Pubitemid 32285467)
16. Betancor-Fernandez, A.; Perez-Galvez, A.; Sies, H.; Stahl, W. Screening pharmaceutical preparations containing extracts of turmeric rhizome, artichoke leaf, devils claw root and garlic or salmon oil for antioxidant capacity J. Pharm. Pharmacol. 2003, 55 (7) 981-6 (Pubitemid 36916688)
17. Yadav, V. R.; Suresh, S.; Devi, K.; Yadav, S. Effect of cyclodextrin complexation of curcumin on its solubility and antiangiogenic and anti-inflammatory activity in rat colitis model AAPS PharmSciTech 2009, 10 (3) 752-62
18. Quitschke, W. W. Differential solubility of curcuminoids in serum and albumin solutions: implications for analytical and therapeutic applications BMC Biotechnol. 2008, 8, 84
19. Ruby, A. J.; Kuttan, G.; Babu, K. D.; Rajasekharan, K. N.; Kuttan, R. Anti-tumour and antioxidant activity of natural curcuminoids Cancer Lett. 1995, 94 (1) 79-83
20. Tiyaboonchai, W.; Tungpradit, W.; Plianbangchang, P. Formulation and characterization of curcuminoids loaded solid lipid nanoparticles Int. J. Pharm. 2007, 337 (1-2) 299-306 (Pubitemid 46756048)
21. Anand, P.; Thomas, S. G.; Kunnumakkara, A. B.; Sundaram, C.; Harikumar, K. B.; Sung, B.; Tharakan, S. T.; Misra, K.; Priyadarsini, I. K.; Rajasekharan, K. N.; Aggarwal, B. B. Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature Biochem. Pharmacol. 2008, 76 (11) 1590-611
22. Vemula, P. K.; Li, J.; John, G. Enzyme catalysis: tool to make and break amygdalin hydrogelators from renewable resources: a delivery model for hydrophobic drugs J. Am. Chem. Soc. 2006, 128 (27) 8932-8 (Pubitemid 44061551)
23. Ma, Z.; Shayeganpour, A.; Brocks, D. R.; Lavasanifar, A.; Samuel, J. High-performance liquid chromatography analysis of curcumin in rat plasma: application to pharmacokinetics of polymeric micellar formulation of curcumin Biomed. Chromatogr. 2007, 21 (5) 546-52 (Pubitemid 46736190)
24. Liu, K.-H.; Chen, S.-Y.; Liu, D.-M.; Liu, T.-Y. Self-Assembled Hollow Nanocapsule from Amphiphatic Carboxymethyl-hexanoyl Chitosan as Drug Carrier Macromolecules 2008, 41 (17) 6511-6
25. Liu, T. Y.; Chen, S. Y.; Lin, Y. L.; Liu, D. M. Synthesis and characterization of amphiphatic carboxymethyl-hexanoyl chitosan hydrogel: water-retention ability and drug encapsulation Langmuir 2006, 22 (23) 9740-5
26. Braconi, C.; Meng, F.; Swenson, E.; Khrapenko, L.; Huang, N.; Patel, T. Candidate therapeutic agents for hepatocellular cancer can be identified from phenotype-associated gene expression signatures Cancer 2009, 115 (16) 3738-48
27. DSouza, S. S.; DeLuca, P. P. Methods to assess in vitro drug release from injectable polymeric particulate systems Pharm. Res. 2006, 23 (3) 460-74
28. Watson, P.; Jones, A. T.; Stephens, D. J. Intracellular trafficking pathways and drug delivery: fluorescence imaging of living and fixed cells Adv. Drug Delivery Rev. 2005, 57 (1) 43-61 (Pubitemid 39424063)
29. Nam, H. Y.; Kwon, S. M.; Chung, H.; Lee, S. Y.; Kwon, S. H.; Jeon, H.; Kim, Y.; Park, J. H.; Kim, J.; Her, S.; Oh, Y. K.; Kwon, I. C.; Kim, K.; Jeong, S. Y. Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles J. Controlled Release 2009, 135 (3) 259-67
30. Liu, Y.; Dolence, J.; Ren, J.; Rao, M.; Sreejayan, N. Inhibitory effect of dehydrozingerone on vascular smooth muscle cell function J. Cardiovasc. Pharmacol. 2008, 52 (5) 422-9
31. Liu, Y.; Ibricevic, A.; Cohen, J. A.; Cohen, J. L.; Gunsten, S. P.; Frechet, J. M.; Walter, M. J.; Welch, M. J.; Brody, S. L. Impact of hydrogel nanoparticle size and functionalization on in vivo behavior for lung imaging and therapeutics Mol. Pharmaceutics 2009, 6 (6) 1891-902
32. An, Z.; Shi, Q.; Tang, W.; Tsung, C.-K.; Hawker, C. J.; Stucky, G. D. Facile RAFT Precipitation Polymerization for the Microwave-Assisted Synthesis of Well-Defined, Double Hydrophilic Block Copolymers and Nanostructured Hydrogels J. Am. Chem. Soc. 2007, 129 (46) 14493-9 (Pubitemid 350171478)
33. Lo, C. L.; Lin, K. M.; Hsiue, G. H. Preparation and characterization of intelligent core-shell nanoparticles based on poly(D,L-lactide)-g-poly(N- isopropyl acrylamide-co-methacrylic acid) J. Controlled Release 2005, 104 (3) 477-88
34. Verheul, R. J.; van der Wal, S.; Hennink, W. E. Tailorable Thiolated Trimethyl Chitosans for Covalently Stabilized Nanoparticles Biomacromolecules 2010, 11 (8) 1965-71
35. Bachelder, E. M.; Beaudette, T. T.; Broaders, K. E.; Dashe, J.; Fréchet, J. M. J. Acetal-Derivatized Dextran: An Acid-Responsive Biodegradable Material for Therapeutic Applications J. Am. Chem. Soc. 2008, 130 (32) 10494-5
36. Bachelder, E. M.; Beaudette, T. T.; Broaders, K. E.; Fréchet, J. M. J.; Albrecht, M. T.; Mateczun, A. J.; Ainslie, K. M.; Pesce, J. T.; Keane-Myers, A. M. In Vitro Analysis of Acetalated Dextran Microparticles as a Potent Delivery Platform for Vaccine Adjuvants Mol. Pharmaceutics 2010, 7 (3) 826-35
37. Alexander, V, K. Polymer genomics: An insight into pharmacology and toxicology of nanomedicines Adv. Drug Delivery Rev. 2006, 58 (15) 1597-1621
38. Rothenfluh, D. A.; Hubbell, J. A. Integration column: Biofunctional polymeric nanoparticles for spatio-temporal control of drug delivery and biomedical applications Integr. Biol. 2009, 1 (7) 446-51
39. Hassani, L. N.; Hendra, F.; Bouchemal, K. Auto-associative amphiphilic polysaccharides as drug delivery systems Drug Discovery Today 2012, 17 (11-12) 608-14
40. Liu, T. Y.; Lin, Y. L. Novel pH-sensitive chitosan-based hydrogel for encapsulating poorly water-soluble drugs Acta Biomater. 2010, 6 (4) 1423-9
41. Wang, Y. J.; Chien, Y. C.; Wu, C. H.; Liu, D. M. Magnolol-loaded core-shell hydrogel nanoparticles: drug release, intracellular uptake, and controlled cytotoxicity for the inhibition of migration of vascular smooth muscle cells Mol. Pharmaceutics 2011, 8 (6) 2339-49
42. He, Y.; Huang, Y.; Cheng, Y. Structure Evolution of Curcumin Nanoprecipitation from a Micromixer Cryst. Growth Des. 2010, 10 (3) 1021-4
43. Prabaharan, M.; Reis, R. L.; Mano, J. F. Carboxymethyl chitosan-graft-phosphatidylethanolamine: Amphiphilic matrices for controlled drug delivery React. Funct. Polym. 2007, 67 (1) 43-52 (Pubitemid 44960921)
44. Pae, H. O.; Jeong, G. S.; Jeong, S. O.; Kim, H. S.; Kim, S. A.; Kim, Y. C.; Yoo, S. J.; Kim, H. D.; Chung, H. T. Roles of heme oxygenase-1 in curcumin-induced growth inhibition in rat smooth muscle cells Exp. Mol. Med. 2007, 39 (3) 267-77
45. Kim, J. H.; Shim, J. S.; Lee, S. K.; Kim, K. W.; Rha, S. Y.; Chung, H. C.; Kwon, H. J. Microarray-based analysis of anti-angiogenic activity of demethoxycurcumin on human umbilical vein endothelial cells: crucial involvement of the down-regulation of matrix metalloproteinase Jpn. J. Cancer Res. 2002, 93 (12) 1378-85 (Pubitemid 36104878)
46. Rutherford, C.; Martin, W.; Salame, M.; Carrier, M.; Anggard, E.; Ferns, G. Substantial inhibition of neo-intimal response to balloon injury in the rat carotid artery using a combination of antibodies to platelet-derived growth factor-BB and basic fibroblast growth factor Atherosclerosis 1997, 130 (1-2) 45-51 (Pubitemid 27158028)
47. Slepian, M. J.; Massia, S. P.; Dehdashti, B.; Fritz, A.; Whitesell, L. Beta3-integrins rather than beta1-integrins dominate integrin-matrix interactions involved in postinjury smooth muscle cell migration Circulation 1998, 97 (18) 1818-27 (Pubitemid 28213626)
48. Iversen, T.-G.; Skotland, T.; Sandvig, K. Endocytosis and intracellular transport of nanoparticles: Present knowledge and need for future studies Nano Today 2011, 6 (2) 176-85
49. Chithrani, B. D.; Chan, W. C. W. Elucidating the Mechanism of Cellular Uptake and Removal of Protein-Coated Gold Nanoparticles of Different Sizes and Shapes Nano Lett. 2007, 7 (6) 1542-50 (Pubitemid 47140422)
50. Brodsky, F. M.; Chen, C. Y.; Knuehl, C.; Towler, M. C.; Wakeham, D. E. Biological basket weaving: formation and function of clathrin-coated vesicles Annu. Rev. Cell Dev. Biol. 2001, 17, 517-68 (Pubitemid 33096185)
51. Watson, P.; Jones, A. T.; Stephens, D. J. Intracellular trafficking pathways and drug delivery: fluorescence imaging of living and fixed cells Adv. Drug Delivery Rev. 2005, 57 (1) 43-61 (Pubitemid 39424063)
52. Yu, Y. M.; Lin, H. C. Curcumin prevents human aortic smooth muscle cells migration by inhibiting of MMP-9 expression Nutr., Metab. Cardiovasc. Dis. 2010, 20 (2) 125-32
53. Parsons, J. T. Focal adhesion kinase: the first ten years J. Cell Sci. 2003, 116 (Part 8) 1409-16 (Pubitemid 36527488)
54. Pan, C. H.; Chen, C. W.; Sheu, M. J.; Wu, C. H. Salvianolic acid B inhibits SDF-1alpha-stimulated cell proliferation and migration of vascular smooth muscle cells by suppressing CXCR4 receptor Vasc. Pharmacol. 2012, 56 (1-2) 98-105